October 2021: UK life sciences translation services company, Conversis Life Sciences (“Conversis”) has acquired Zebra Translations. Conversis was advised by Kinetix Critchleys Corporate Finance (KCCF).
Headquartered in Oxford, England, Conversis is a highly niche translation services company, with a specialism in life science clinical trials and, in particular, patient recruitment and retention. Its clients include global Clinical Research Organizations and pharmaceutical companies.
The acquisition gives Conversis both additional scale and a highly complementary additional specialism via Zebra’s expertise in medical and pharmaceutical regulatory affairs translation.
Together, the two organisations have an arguably unique combination of technical expertise and a reputation for excellence in life sciences translation.
Craig Harrison, CEO of Conversis “We really appreciate all the hard work put in by Kinetix Critchleys over the last few months. We wouldn’t have got to this point without their advice and assistance.’
KCCF Partner Ray Barrett commented:“Conversis is a fantastic business that operates in a truly niche space. We are delighted to have assisted it on the acquisition of a highly complementary and equally specialist business. Well done and best of luck for the future to both”
Conversis’s announcement can be found here.
About us: Kinetix Critchleys Corporate Finance is an independent corporate advisory boutique, with sector specialisms in Sustainability & Cleantech, Hard & Soft tech, Financial Services including Fintech, and Healthcare. We provide strategic and M&A advice, business planning, valuations and fund raising services.